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Abstract
Background: Some studies of nosocomial bloodstream infection (nBSI) have demonstrated a
higher mortality for polymicrobial bacteremia when compared to monomicrobial nBSI. The
purpose of this study was to compare differences in systemic inflammatory response and mortality
between monomicrobial and polymicrobial nBSI with Pseudomonas aeruginosa.
Methods: We performed a historical cohort study on 98 adults with P. aeruginosa (Pa) nBSI. SIRS
scores were determined 2 days prior to the first positive blood culture through 14 days afterwards.
Monomicrobial (n = 77) and polymicrobial BSIs (n = 21) were compared.
Results: 78.6% of BSIs were caused by monomicrobial P. aeruginosa infection (MPa) and 21.4% by
polymicrobial P. aeruginosa infection (PPa). Median APACHE II score on the day of BSI was 22 for
MPa and 23 for PPa BSIs. Septic shock occurred in 33.3% of PPa and in 39.0% of MPa (p = 0.64).
Progression to septic shock was associated with death more frequently in PPa (OR 38.5, CI95 2.9–
508.5) than MPa (OR 4.5, CI95 1.7–12.1). Maximal SIR (severe sepsis, septic shock or death) was
seen on day 0 for PPa BSI vs. day 1 for MPa. No significant difference was noted in the incidence of
organ failure, 7-day or overall mortality between the two groups. Univariate analysis revealed that
APACHE II score ≥20 at BSI onset, Charlson weighted comorbidity index ≥3, burn injury and
respiratory, cardiovascular, renal and hematologic failure were associated with death, while age,
malignant disease, diabetes mellitus, hepatic failure, gastrointestinal complications, inappropriate
antimicrobial therapy, infection with imipenem resistant P. aeruginosa and polymicrobial nBSI were
not. Multivariate analysis revealed that hematologic failure (p < 0.001) and APACHE II score ≥20
at BSI onset (p = 0.005) independently predicted death.
Conclusion: In this historical cohort study of nBSI with P. aeruginosa, the incidence of septic shock
and organ failure was high in both groups. Additionally, patients with PPa BSI were not more acutely
ill, as judged by APACHE II score prior to blood culture positivity than those with MPa BSI. Using
multivariable logistic regression analysis, the development of hematologic failure and APACHE II
score ≥20 at BSI onset were independent predictors of death; however, PPa BSI was not.
Published: 31 October 2005
BMC Infectious Diseases 2005, 5:94 doi:10.1186/1471-2334-5-94
Received: 15 June 2005
Accepted: 31 October 2005
This article is available from: http://www.biomedcentral.com/1471-2334/5/94
© 2005 Marra et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Page 1 of 7
(page number not for citation purposes)
BMC Infectious Diseases 2005, 5:94 http://www.biomedcentral.com/1471-2334/5/94Background
P. aeruginosa is an important nosocomial BSI pathogen
with a high associated mortality [1]. Although the fre-
quency of Gram-negative sepsis has diminished over the
last 20 years, the incidence of polymicrobial nBSI infec-
tion has increased [2]. In addition, the mortality associ-
ated with nosocomial bloodstream infections,
particularly those occurring in the intensive care setting, is
greater than that of community acquired BSI [3].
Prior studies of nosocomial bloodstream infection (nBSI)
have reported a higher associated mortality with pol-
ymicrobial nBSI than with monomicrobial nBSI [4].
These studies compared polymicrobial infections with
monomicrobial infections caused by diverse pathogens
[5]. As such, few investigators have analyzed the clinical
significance of polymicrobial versus monomicrobial BSI
with a specific pathogen [6]. In addition, a major diffi-
culty in interpreting prior studies is both the marked het-
erogeneity of variables and the varied definitions of
polymicrobial infection [4,6,7]. Little information exists
about the systemic inflammatory response in polymicro-
bial BSI [4,5].
The purpose of this study was to evaluate and compare the
inflammatory response, clinical course, and outcomes of
monomicrobial and polymicrobial nosocomial BSI due
to Pseudomonas aeruginosa.
Methods
Setting
The Virginia Commonwealth University Medical Center
(VCUMC) is an 820-bed tertiary care facility in Richmond,
Virginia. The hospital houses 9 intensive care units
(ICUs), including pediatric ICUs and a burn unit. Approx-
imately 30,000 patients are admitted annually.
Study design
Using the Surveillance and Control of Pathogens of Epide-
miological Importance (SCOPE) database of bloodstream
infections occurring at 49 U.S. hospitals [1], we identified
all patients with a diagnosis of nBSI due to P. aeruginosa
at VCUMC from January 1, 1996 through December 31,
2003. Patients were considered to have had BSI due to P.
aeruginosa if ≥ 1 blood culture was positive for this organ-
ism. Each patient was only included once at the time of
the first BSI. Bacteremia was defined as polymicrobial if
microorganisms other than P. aeruginosa were recovered
from the blood culture within a 24 h period. If the blood-
stream isolate was a potential skin contaminant (e.g.,
diphtheroids, Propionibacterium spp, Bacillus spp, coag-
ulase-negative staphylococci, or micrococci), the presence
of an intravascular catheter and the initiation of targeted
antimicrobial therapy were required for the diagnosis, as
well as at least 1 of the following findings: temperature of
>38.0°C or < 36.0°C, chills, and or systolic blood pres-
sure of <90 mmHg. Clinical data were concurrently col-
lected by infection control practitioners using a
standardized case report form. The data collected rou-
tinely included age, gender, location of the patient (ward
vs. ICU), clinical service, duration of hospitalization prior
to onset of BSI, predisposing clinical conditions, and
bloodstream pathogen. Predisposing clinical conditions
were required to be present prior to BSI and included neu-
tropenia (defined as an absolute neutrophil count <500/
µl), peritoneal or hemodialysis, and central venous cathe-
ters. Sources of secondary BSI were identified by cultures
obtained from distant sites that yielded the same patho-
gen. Adverse outcomes that occurred during the hospital
stay were recorded. These included organ failure and mor-
tality (7-day and overall hospital). The clinical condition
of each patient was classified daily according to systemic
inflammatory response syndrome (SIRS) criteria [SIRS,
sepsis, severe sepsis or septic shock] and APACHE II scores
from two days prior to the first positive blood culture
through 14 days afterwards [8,9]. The severity of underly-
ing disease for each patient was classified using the Charl-
son weighted comorbidity index [10]. Patients who had
nosocomial BSI due to monomicrobial P. aeruginosa
(MPa) were compared to patients who had nosocomial
BSI due to polymicrobial P. aeruginosa (PPa) nBSI.
Definitions
The patient's physiological conditions prior to the BSI and
on the day of BSI were assessed using the APACHE II score
[9]. The clinical condition of each patient during the
bloodstream infection was classified daily as SIRS, sepsis,
severe sepsis or septic shock using criteria previously pub-
lished by the American College of Chest Physicians / Soci-
ety of Critical Care Medicine (ACCP/SCCM) [8]. Systemic
Inflammatory Response Syndrome (SIRS) was defined as
two or more of the following: (a) temperature >38°C or
<36°C, (b) heart rate >90 beats per minute, (c) respiratory
rate >20 breaths per minute or a PaCO2 <32 mmHg, or (d)
white blood cell count >12 × 109/L or <4 × 109/L or the
presence of more than 10% immature neutrophils.
Sepsis was defined as SIRS associated with P. aeruginosa
isolated from at least one blood culture. Severe sepsis was
associated with organ dysfunction, hypotension or sys-
temic manifestations of hypoperfusion. Septic shock was
defined as sepsis associated with hypotension unrespon-
sive to intravenous fluid challenge or the need for a vaso-
pressor agent. The presence of organ system failure at the
time of BSI and during the clinical course was assessed
using the criteria described by Fagon [11]. Nosocomial
infection and sources of infection were defined according
to Centers for Disease Control and Prevention (CDC) cri-
teria [12]. Adequate empiric antimicrobial treatment was
defined as therapy administered within 24 hours afterPage 2 of 7
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administration of any antimicrobial agent to which the P.
aeruginosa and the other co-pathogens were susceptible
[13], except when a susceptible aminoglycoside was used
in conjunction with another antimicrobial to which the
organisms were resistant or when a susceptible aminogly-
coside was used alone.
Microbiological methods
Blood cultures (each consisting of aerobic and anaerobic
bottles) were processed at the VCUMC clinical laboratory
using the BACTEC® 9240 blood culture system (Becton
Dickinson, Sparks MD).
Statistical analysis
For continuous variables, mean values were compared
using two sample t-tests for independent samples. Differ-
ences in proportions were compared using a Chi-square
test or Fisher's exact test when appropriate. Mean values
were reported ± 1 SD. All tests of significance are two-
tailed. When collinearity was identified, the variable with
the greatest measure of association was included in the
multivariate analysis. Odds ratios were calculated for all
variables. Ninety five percent confidence intervals were
calculated for all odd ratios. Variables found to be signifi-
cant in univariate analysis were then entered into a multi-
variate model. Alpha was set at 0.05. All statistical
Table 1: Patient characteristics and outcomes, stratified by polymicrobial infection.
VARIABLES Polymicrobial (n = 21) Monomicrobial (n = 77) P
N % N %
Demographic characteristics
Age >60 years 7 33.3 29 37.7 0.71
Male gender 17 81.0 46 59.7 0.72
Mean LOS prior to nBSI (days) ± SD (range) 26 ± 28.6 (5–121) - 33 ± 44.7 (2–323) - 0.38
Mean hospital stay (days) ± SD (range) 46.9 ± 32.0 (9–128) - 69.0 ± 75.4 (5–415) - 0.05
ICU stay 19 90.5 63 81.8 0.51
Underlying conditions
Charlson score ≥3 4 19.0 23 29.9 0.32
Burn injury 9 42.9 8 10.4 0.002
Diabetes mellitus 5 23.8 17 22.1 1.0
Neoplasia 1 4.8 19 24.7 0.064
Neutropenia 0 - 10 13.0 0.11
Gastrointestinal diseases 4 19.0 16 20.8 1.0
Therapeutics
Mechanical ventilation 15 71.4 47 61.0 0.38
Central venous line 19 90.5 64 83.1 0.51
Hemodialysis 3 14.3 12 15.6 1.0
TPN 3 14.3 21 27.3 0.22
Transfusion 8 38.1 20 26.0 0.28
Prior antibiotics 18 85.7 65 84.4 0.88
Conditions related to the clinical course
APACHE II score ≥20 at BSI onset 15 71.4 50 64.9 0.58
Mean time to appropriate antimicrobial therapy (days) 3.40 - 1.7 - 0.029
Inadequate antibiotic therapy 18 85.7 37 48.1 0.002
Imipenem resistant P. aeruginosa 6 28.6 20 26.0 0.81
Outcomes
Respiratory failure 15 71.4 58 75.3 0.72
Cardiovascular failure 7 33.3 30 39.0 0.64
Renal failure 11 52.4 28 36.4 0.18
Hematologic failure 6 28.6 26 33.8 0.65
Hepatic failure 2 9.5 10 13.0 1.0
7-day mortality 6 28.6 16 20.8 0.56
Overall mortality 8 38.1 37 48.1 0.42Page 3 of 7
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Social Sciences software (SPSS, Chicago, IL, USA).
Results
Study population and patient characteristics
A total of 160 nosocomial P. aeruginosa BSIs were identi-
fied at VCUMC during the eight-year study period. Of
these, 19 clinically significant episodes of BSI (11.9%)
were identified in pediatric patients (<18 years of age), 92
episodes were monomicrobial, and 49 episodes were pol-
ymicrobial BSI. Fifteen monomicrobial and 12 pol-
ymicrobial BSIs had incomplete medical records. In 16
cases co-pathogens were recovered from the blood culture
>24 hours after the isolation of Pseudomonas aeruginosa.
The remaining 77 monomicrobial and 21 polymicrobial
BSIs caused by P. aeruginosa were included in the analy-
sis.
Proportions and means for the different variables in the
two groups are listed in Table 1. There were no significant
differences in age or gender between the two groups (p =
0.71 and p = 0.72, respectively). Burn injuries were more
commonly seen in cases of polymicrobial P. aeruginosa
BSI vs. monomicrobial cases (42.9% vs. 10.4%, p =
0.002). Underlying malignancy was more commonly seen
in the monomicrobial P. aeruginosa BSI cohort (24.7% vs.
4.8%, p = 0.064). No statistically significant differences
were observed in the proportion of patients with diabetes
mellitus or gastrointestinal complications between the
two BSI groups. No difference was also observed in Charl-
son scores ≥3 between the two groups (19.0% for PPa vs.
29.9% for MPa, p = 0.32). Although the majority of
patients acquired P. aeruginosa BSI in the intensive care
unit setting, no statistically significant differences were
noticed between the two comparison groups (90.5% for
PPa vs. 81.8% for MPa, p = 0.51). A central venous cathe-
ter was present in more than three-quarters of both groups
(90.5% in PPa vs. 83.1% in MPa, p = 0.51). Twenty-seven
percent of the MPa BSI patients received total parental
nutrition compared to 14.3% of PPa BSI patients (p =
0.22). A greater proportion of PPa BSI patients (38.1%)
received blood transfusions compared with 26.0% of MPa
BSI patients; however, this was not statistically significant
(p = 0.28). More than half of patients in both groups
needed ventilatory support (71.4% in PPa vs. 61.0% in
MPa, p = 0.38) prior to the onset of BSI. There was no dif-
ference in the use of any class of antimicrobials prescribed
prior to Pseudomonas BSI between the two groups (85.7%
in PPa vs. 84.4% in MPa, p = 0.88).
The mean interval between hospitalization and the onset
of BSI did not differ between the monomicrobial and pol-
ymicrobial groups (26 ± 28.6 days vs. 33 ± 44.7 days, p =
0.38). However, the overall hospital mean length of stay
was significantly longer for MPa BSI (69.0 ± 75.4 vs. 46.9
± 32.0 days, p = 0.05).
Microbiological features
78.6% of BSIs were caused by monomicrobial P. aerugi-
nosa infection (MPa) and 21.4% by polymicrobial P. aer-
Table 2: Characteristics of 26 co-pathogens isolated in 21 cases of polymicrobial P. aeruginosa BSI.
Microorganisms Polymicrobial BSI cases (n = 21)
N %
Number of agents (associated with P. aeruginosaBSI)
1 17 80.9
2 3 14.3
3 1 4.8
Agents (n = 26)
CNS 4 15.4
Staphylococcus aureus* 3 11.5
Enterococcus faecalis 1 3.8
Enterococcus faecium** 2 7.7
Streptococcus pneumoniae 1 3.8
Acinetobacter baumannii 4 15.4
Burkholderia cepacia 2 7.7
Enterobacter cloacae 1 3.8
Klebsiella pneumoniae 3 11.5
Klebsiella oxytoca 1 3.8
Serratia marcescens 1 3.8
Candida albicans 3 11.5
CNS = coagulase-negative staphylococci
*Two methicillin-resistant S. aureus
**One vancomycin-resistant E. faeciumPage 4 of 7
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associated with polymicrobial P. aeruginosa BSI were
coagulase-negative staphylococci (16.6%), Acinetobacter
baumannii (16.6%), Staphylococcus aureus (12.5%) and
Candida albicans (12.5%) (Table 2). Polymicrobial infec-
tion with more than 2 organisms was seen in 19.1% of
PPa BSI cases. No statistically significant differences were
observed in the proportion of imipenem resistance in P.
aeruginosa isolates between the two groups (28.6% for
PPa vs. 26.0% for MPa, p = 0.81).
Clinical course
Septic shock occurred in 33.3% of PPa and in 39.0% of
MPa (p = 0.64). Progression to septic shock was associated
with death more frequently in PPa (OR 38.5, CI95 2.9–
508.5) than MPa (OR 4.5, CI95 1.7–12.1). Maximal SIR
(severe sepsis, septic shock or death) was seen on day 0 for
PPa BSI vs. day 1 for MPa (Figure 1). Median APACHE II
scores on the day of BSI were 23 in the PPa group and 22
in the MPa group. There was also no difference in
APACHE II scores at 14 days post-BSI diagnosis between
the MPa and PPa groups (Figure 2). Appropriate empiric
antimicrobials were begun within 24 hours in 59.6% of
MPa and in 14.3% of PPa (p = 0.002). In addition the
time to adequate therapy was twice as long for patients
with PPa infection (3.4 days vs. 1.7 days, p = 0.029). No
significant difference was noted in the incidence of organ
failure, 7-day mortality, or overall mortality between the
two groups as seen in table 1.
Univariate analysis revealed that APACHE II score ≥20 at
BSI onset, Charlson score, burn injury, and respiratory,
cardiovascular, renal and hematologic failure were associ-
ated with death (table 3). Age, malignancy, diabetes mel-
litus, hepatic failure, gastrointestinal complications,
inappropriate empiric antimicrobial therapy, infection
with imipenem-resistant P. aeruginosa, and polymicrobial
infection were not significant predictors of mortality on
univariate analysis. Using logistic regression analysis, the
following variables were independent predictors for death
(table 3): hematologic failure (OR 16.9; CI95 3.9–73.2)
and APACHE II score ≥20 at BSI onset (OR 9.7; CI95 1.9–
47.9).
Discussion
As polymicrobial BSI with P. aeruginosa is associated with
high mortality, we decided to investigate whether the sys-
temic inflammatory response with polymicrobial P. aeru-
ginosa BSI is more intense than the systemic inflammatory
response associated with monomicrobial P. aeruginosa
BSI. During the study period, we found one-fifth of cases
were polymicrobial. Since our intention was to analyze
the 14-day period after P. aeruginosa BSI for the intensity
of the systemic inflammatory response, we adopted a
more conservative definition of polymicrobial BSI (all
organisms isolated in the 24 hour period following the
first culture positive for P. aeruginosa) rather than the
more standard definition (organisms isolated within 48
hours) [14] in order to minimize misclassification of
serial monomicrobial infections as polymicrobial infec-
tions. It should be noted that the proportion of Pseu-
domonas BSI cases that were polymicrobial was lower at
our hospital than in the SCOPE hospitals overall, where
32.7% of the 1,256 nosocomial Pseudomonas BSI cases
were polymicrobial.
It is also important to note that 19.1% of the patients with
PPa BSI had 2 or 3 co-pathogens associated with P. aerugi-
nosa. Coagulase negative staphylococci (CNS) were found
in 15.4% of the PPa BSIs. It is often difficult to determine
the pathogenic role of coagulase-negative staphylococci
when these organisms are isolated in blood cultures. To
avoid this, we utilized more strict criteria for classification
of skin flora as pathogens. In addition, in only one of the
Mean APACHE II scores in patients with P. aeruginosa nBSI stratified by polymi robial infectionFigur  2
Mean APACHE II scores in patients with P. aeruginosa nBSI 
stratified by polymicrobial infection.
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phylococci (CNS) was a co-pathogen was a third organ-
ism also found. However, in this particular case, multiple
blood cultures yielded both Pseudomonas and CNS, which
leads us to believe that both organisms played a patho-
genic role.
Acinetobacter baumannii was found in 15.4% of the pol-
ymicrobial cases. A previous study found that Acineto-
bacter spp. may be a co-pathogen in P. aeruginosa
polimycrobial BSI [6]. Although both pathogens are non-
fermentative Gram-negative bacteria causing nosocomial
infections, principally in intensive care units, they show
different epidemiologic characteristics [1].
Interestingly, no significant difference was noted between
the MPa BSI and PPa BSI cohorts with respect to gastroin-
testinal complications, such as bowel perforation or gas-
trointestinal procedures. As such, a gastrointestinal source
for the etiology of the polymicrobial BSI is not clearly
defined. However, burn injury was more common in PPa
BSI (p = 0.002). The loss of the natural cutaneous barrier
to infection likely led to microbial colonization and sub-
sequent invasion of the bloodstream [15]. Of note was
that malignant conditions were more commonly associ-
ated with MPa BSI than PPa BSI.
No difference in APACHE II scores was noted between the
two comparison groups during 14 days of follow up. On
analysis of severe sepsis, septic shock and death, no statis-
tically significant differences were observed between the
MPa and PPa groups. A previous study by Aliaga et al.
showed that patients with polymicrobial infection involv-
ing P. aeruginosa were worse clinically and developed
shock more frequently [6]. However, the severity of
underlying diseases chosen by these authors was only
evaluated by the McCabe classification. In our study, the
Charlson weighted comorbidity index and serial APACHE
II scores were used to assess the patients' severity of illness
(figure 2).
Our study also demonstrated the difficulty in choosing
empiric antimicrobial treatment for polymicrobial infec-
tions at the time P. aeruginosa was isolated. This difficulty
is even greater if organisms such as VRE or Candida are co-
pathogens where it is likely that therapy will be inade-
quate until all pathogens have been identified [13]. This
at least partially explains the difference observed in inad-
equate empiric treatment in patients with PPa compared
to patients with MPa (85.7% vs. 48.1%, p = 0.025). It is
also important to note that there was no difference in imi-
penem resistance between the PPa and MPa groups (p =
0.81).
By univariate analysis several organ dysfunctions (respira-
tory, cardiovascular, renal and hematologic) were associ-
ated with death, but age, hepatic failure, inappropriate
antimicrobial therapy, imipenem resistance and pol-
ymicrobial infection were not. The clinical belief that pol-
ymicrobial BSI portends a worse prognosis than
monomicrobial BSI was not demonstrated in our study.
Other studies, however, have associated polymicrobial
infection with higher mortality [4,5]. Another surprising
finding was that the mean length of hospital stay was
higher for the monomicrobial group than the polymicro-
bial group. Thus, our findings suggest that the outcome of
P. aeruginosa BSI is more closely related to the underlying
physiological response to sepsis than it is to polymicro-
bial infection. However, it must be emphasized that
because of the relatively small sample size of our study, a
Table 3: Risk factors for in-hospital mortality in patients with P. aeruginosa nosocomial bloodstream infection.
VARIABLES Died (n = 45) Recovered (n = 53) Univariate analysis Multivariate analysis
N % N % OR CI 95% OR CI 95%
Age >60 years 18 40.0 18 34.0 1.3 0.6–2.9
Burn injury 12 26.7 5 9.4 3.5 1.1–10.8 3.2 0.6–18.2
Diabetes mellitus 10 22.2 12 22.6 0.9 0.4–2.5
Gastrointestinal complication 6 13.3 14 26.4 0.4 0.1–1.2
Neoplasia 11 24.4 9 17.0 1.6 0.6–4.2
APACHE II score ≥20 at BSI onset 41 91.1 24 45.3 12.7 3.9–39.5 9.7 1.9–47.9
Charlson score ≥3 17 37.8 10 18.9 2.6 1.0–6.5 2.7 0.7–10.1
Respiratory failure 39 86.7 34 64.2 3.6 1.3–10.1 1.4 0.3–7.2
Cardiovascular failure 26 57.8 11 10.8 5.2 2.1–12.7 2.6 0.7–9.3
Renal failure 25 55.6 14 26.4 3.5 1.5–8.1 1.3 0.4–4.2
Hematologic failure 26 57.8 6 11.3 10.7 3.8–30.2 16.9 3.9–73.2
Hepatic failure 8 17.8 4 7.5 2.6 0.7–9.5
Inadequate antibiotic therapy 26 57.8 29 54.7 1.1 0.7–1.7
Imipenem resistant P. aeruginosa 16 35.6 10 18.9 2.37 0.9–5.9
Polymicrobial infection 8 17.8 13 24.5 0.7 0.2–1.8Page 6 of 7
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monomicrobial and polymicrobial groups would be nec-
essary to detect a statistically significant difference in SIRS,
organ failure or mortality rate. In the SCOPE hospitals
overall, the crude mortality of polymicrobial P. aeruginosa
BSI (42.4%) was significantly higher than that seen with
monomicrobial P. aeruginosa BSI (34.8%), (p = 0.01).
Thus, the smaller sample size in our study could have led
to a type II error in our finding of no significant difference
in mortality between mono- and polymicrobial BSI.
In conclusion, in patients with P. aeruginosa nBSI, one-
fifth of cases are polymicrobial, the incidence of septic
shock and organ failure is high, patients with PPa BSI are
not more severely ill prior to infection than those with
MPa BSI, and APACHE II score ≥20 at BSI onset and the
development of hematologic failure are independent pre-
dictors of death.
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